Tacrolimus and the pigmentary system

Dermatology

Volumn 210, Issue 3, 2005, Pages 177-178

  Taieb A ^a  

^a HÔPITAL SAINT ANDRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOSPORIN A; TACROLIMUS;

DRUG TISSUE LEVEL; EDITORIAL; HAIR DISEASE; HUMAN; HYPERPIGMENTATION; NONHUMAN; PIGMENT DISORDER; POLIOSIS; PRIORITY JOURNAL; SKIN PIGMENTATION; VITILIGO;

CALCINEURIN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SKIN PIGMENTATION; TACROLIMUS;

EID: 17244368252     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083504     Document Type: Editorial

References (10)

1. Huai Q, Kim HY, Liu Y, Zhao Y, Mondragon A, Liu JO, Ke H: Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc Natl Acad Sci USA 2002;99:12037-1242.
2. Fisher GJ, Duell EA, Nickoloff BJ, Annesley TM, Kowalke JK, Ellis CN, Voorhees JJ: Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media. J Invest Dermatol 1986;91:142-146.
3. Brady AJ, Wing AJ: Hyperpigmentation due to cyclosporin therapy. Nephrol Dial Transplant 1989;4:309-310.
4. Ozkaya-Bayazit E, Diz-Kucukkaya R, Akasya E, Buyukbabani N, Oncu S, Pekcelen Y: Bullous acral erythema and concomitant pigmentation on the face and occluded skin. J Eur Acad Dermatol Venereol 2000;14:139-140.
5. Rebora A, Delmonte S, Parodi A: Cyclosporin A-induced hair darkening. Int J Dermatol 1999;38:229-230.
6. Asensio V, del Pozo LJ, Asensio M, Lerida MT: Megalotrichiasis and poliosis caused by cyclosporin A. Med Clin (Barc) 1991;97:39.
7. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB: A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003;139:581-585.
8. Grimes PE, Morris R, Avaniss-Aghajani E, Soriano T, Meraz M, Metzger A: Topical tacrolimus therapy for vitiligo: Therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 2004;51:52-61.
9. Fricain JC, Sibaud V, Campana F, Lepreux S, Taïeb A: Mucosal pigmentation after oral lichen planus treatment with topical tacrolimus. Dermatology 2005;210:229-232.
10. Lee JY, Kang WH: Effect of cyclosporin A on melanogenesis in cultured human melanocytes. Pigment Cell Res 2003;16:504-508.